CDKN2A Gene Deletions and Loss of P16 Expression Occur in Osteosarcomas That Lack RB Alterations

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)65556-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

CDKN2A and MTAP Deletions in Peritoneal Mesotheliomas Are Correlated With Loss of P16 Protein Expression and Poor Survival

Modern Pathology
Forensic MedicinePathology
2010English

Loss of P16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated With Worse Outcome and Younger Age in Thymic Carcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

P16/Cdkn2 Alterations and pRb Expression in Oesophageal Squamous Carcinoma

Molecular Pathology
1998English

Rb and P53 Gene Deletions in Lung Adenocarcinomas From Irradiated and Control Mice

1997English

Loss of NFAT5 Results in Renal Atrophy and Lack of Tonicity-Responsive Gene Expression

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

The P16 (CDKN2A) Gene Is Involved in the Growth of Neuroblastoma Cells and Its Expression Is Associated With Prognosis of Neuroblastoma Patients

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Alterations of Tumor Suppressor Gene P16 INK4a in Pancreatic Ductal Carcinoma

BMC Gastroenterology
MedicineGastroenterology
2005English

Do Blood Cells Mimic Gene Expression Profile Alterations Known to Occur in Muscular Adaptation to Endurance Training ?

European Journal of Applied Physiology
Sports MedicinePublic HealthSports ScienceEnvironmentalOrthopedicsMedicinePhysiologyOccupational Health
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy